Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 1;8(2):1292-301.
eCollection 2015.

Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis

Affiliations

Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis

Ying Qu et al. Int J Clin Exp Pathol. .

Abstract

Background: Glycyrrhizin has various pharmacological effects including hepato-protection. This study aimed to investigate the potential mechanism underlying the protective effects of 18α-glycyrrhizin (18α-GL) in rats with carbon tetrachloride (CCl4) induced liver fibrosis.

Methods: Male Sprague-Dawley (SD) rats were randomly divided into control group, fibrosis group, 25 mg/kg 18α-GL group and 12.5 mg/kg 18α-GL group. Rats in experimental groups were subcutaneously injected with 40% CCl4 twice weekly for 8 weeks. Immunohistochemical examination was carried out to detect the protein expressions of collagen I, collagen III, TGF-β1, p-Smad2, p-Smad3, Smad 7 and SP-1, in the liver, and the mRNA and protein expressions of these genes were determined in the liver by real time PCR and Western blot assay, respectively.

Results: 18α-GL ameliorated histological changes and significantly suppressed collagen deposition. 18α-GL significantly decreased the mRNA expressions of TGF-β1, Smad2, Smad3 and SP-1 in the liver. Immunohistochemical staining revealed that TGF-β1, p-Smad2, p-Smad3 and SP-1 expressions reduced following 18α-GL therapy. Western blot assay showed p-Smad2, p-Smad3, smad2 and smad3 expressions decreased after 18α-GL treatment. The mRNA and protein expression of Smad7 remained unchanged.

Conclusion: 18α-GL is able to attenuate CCl4 induced liver fibrosis in rat.

Keywords: 18α-glycyrrhizin; Smad; TGF-β1; collagen; liver fibrosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histological examination of the liver in different groups. H&E staining: (A-D) Masson staining: (E-H) Representative photographs of control group (A, E), liver fibrosis (B, F), 12.5 mg/kg 18α-GL group (C, G) and 25 mg/kg 18α-GL group (D, H) (100×).
Figure 2
Figure 2
Effects of 18α-GL on hypdroxyproline in THE rat liver. Data are expressed as means ± standard deviation *P<0.05 vs fibrosis group.
Figure 3
Figure 3
Effects of 18α-GL on the collagen I and III expression in Rat Liver (immunohistochemistry). Collagen I (A-D) and collagen III (E-H) expression of control group (A, E), liver fibrosis group (B, F), 12.5 mg/kg 18α-GL group (C, G) and 25 mg/kg 18α-GL group (D, H). Positive cells had brown granules (100×). (I, J) Ratio of collagen I and III expression. Data are expressed as means ± standard deviation *P<0.05 vs liver fibrosis group.
Figure 4
Figure 4
Effects of 18αGL on the TGF/Smad mRNA expression. qPCR was performed to detect the mRNA expression of TGF-β1, Smad2/3/7 and SP-1. Data are expressed as means ± standard deviation *P<0.05 vs liver fibrosis group.
Figure 5
Figure 5
Immunohistochemical staining of TGF-β/Smad in the rat liver after 18α-GL treatment. Immunohistochemistry was performed to detect the protein expression of TGF-β1 (A-D), p-smad2 (E-H), p-Smad3 (I-L), Smad7 (M-P) and SP-1 (Q-T) in control group, liver fibrosis group, and 12.5 mg/kg 18α-GL group and 25 mg/kg 18α-GL group. Positive cells had brown granules (100×).
Figure 6
Figure 6
Western blot assay of Smad2/3 and p-smad2/3 expression in the rat liver after 18α-GL treatment.

Similar articles

Cited by

References

    1. Pellicoro A, Ramachandran P, Iredale JP. Reversibility of liver fibrosis. Fibrog Tiss Rep. 2012;5:S26. - PMC - PubMed
    1. Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis. 2005;10:927–939. - PubMed
    1. Jäättelä M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene. 2004;23:2746–2756. - PubMed
    1. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125–172. - PMC - PubMed
    1. Ferrucci LM, Bell BP, Dhotre KB, Manos MM, Terrault NA, Zaman A, Murphy RC, VanNess GR, Thomas AR, Bialek SR. Complementary and alternative medicine use in chronic liver disease patients. J Clin Gastroenterol. 2010;44:e40. - PMC - PubMed

Publication types

LinkOut - more resources